Cargando...
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
Accumulating neurological disability has a substantial impact on the lives of patients with multiple sclerosis (MS). As well as the established Expanded Disability Status Scale (EDSS), several other outcome measures are now available for assessing disability progression in MS. This review extends th...
Guardado en:
| Publicado en: | CNS Drugs |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6061412/ https://ncbi.nlm.nih.gov/pubmed/29926371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-018-0530-8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|